Posted by Michael Wonder on 30 Sep 2016
EMA publishes EPAR for Truberzi
29 September - The EMA has published an EPAR for Allergan's Truberzi (eluxadoline).
The EC approved Truberzi on 19 September 2016 for use in adults for the treatment of irritable bowel syndrome with diarrhoea.
